355 related articles for article (PubMed ID: 20959827)
21. Factors Associated with Colorectal Cancer Screening among Mississippi Adults: Findings from the Behavioral Risk Factor Surveillance System.
Zhang WQ; Tang SJ; Dobbs TE; Zhang L
South Med J; 2020 Jul; 113(7):360-365. PubMed ID: 32617599
[TBL] [Abstract][Full Text] [Related]
22. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
[TBL] [Abstract][Full Text] [Related]
23. Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort.
Bjerrum A; Andersen O; Fischer A; Lindebjerg J; Lynge E
Int J Cancer; 2017 Aug; 141(3):503-511. PubMed ID: 28463410
[TBL] [Abstract][Full Text] [Related]
24. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
[TBL] [Abstract][Full Text] [Related]
25. Inequalities in cancer screening participation: examining differences in perceived benefits and barriers.
Smith SG; McGregor LM; Raine R; Wardle J; von Wagner C; Robb KA
Psychooncology; 2016 Oct; 25(10):1168-1174. PubMed ID: 27309861
[TBL] [Abstract][Full Text] [Related]
26. Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme.
Morris S; Baio G; Kendall E; von Wagner C; Wardle J; Atkin W; Halloran SP; Handley G; Logan RF; Obichere A; Rainbow S; Smith S; Snowball J; Raine R
Br J Cancer; 2012 Aug; 107(5):765-71. PubMed ID: 22864455
[TBL] [Abstract][Full Text] [Related]
27. The impact of socioeconomic deprivation on the uptake of colorectal cancer screening in London.
Lal N; Singh HK; Majeed A; Pawa N
J Med Screen; 2021 Jun; 28(2):114-121. PubMed ID: 32295488
[TBL] [Abstract][Full Text] [Related]
28. Individual and Geospatial Characteristics Associated With Use and Nonuse of the Fecal Immunochemical Test (FIT) for Colorectal Cancer Screening in an Urban Minority Population.
Ramai D; Etienne D; Ayide G; Fields PJ; Reddy M
J Clin Gastroenterol; 2019; 53(10):744-749. PubMed ID: 30222644
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer among Arab-Israeli women--possible reasons for increased incidence and mortality.
Rainis T; Halloun L; Keren D; Shuv-ami I; Lavy A
J Gastrointest Cancer; 2010 Jun; 41(2):130-4. PubMed ID: 20108055
[TBL] [Abstract][Full Text] [Related]
30. To do or not to do - a survey study on factors associated with participating in the Danish screening program for colorectal cancer.
Nielsen JB; Berg-Beckhoff G; Leppin A
BMC Health Serv Res; 2021 Jan; 21(1):43. PubMed ID: 33413310
[TBL] [Abstract][Full Text] [Related]
31. Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut--a secret-shopper survey.
Patel VB; Nahar R; Murray B; Salner AL
Conn Med; 2013 Apr; 77(4):197-203. PubMed ID: 23691732
[TBL] [Abstract][Full Text] [Related]
32. Factors Associated with Participation in Stool Based Colorectal Screening in Brunei Darussalam.
Chong VH; Kadir L; Kamis Z; Kassim N; Khalil MAM; Tan J; Leong E; Ong SK; Chong CF
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2231-2236. PubMed ID: 32856849
[TBL] [Abstract][Full Text] [Related]
33. Self-reported colorectal cancer screening of Medicare beneficiaries in family medicine vs. internal medicine practices in the United States: a cross-sectional study.
Higgins AY; Doubeni AR; Phillips KL; Laiyemo AO; Briesacher B; Tjia J; Doubeni CA
BMC Gastroenterol; 2012 Mar; 12():23. PubMed ID: 22436107
[TBL] [Abstract][Full Text] [Related]
34. [The populations attitudes to colorectal cancer screening in the Czech Republic].
Král N; Seifert B; Suchánek Š; Zavoral M; Májek O
Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):41-6. PubMed ID: 25872995
[TBL] [Abstract][Full Text] [Related]
35. Use of lower gastrointestinal endoscopy and fecal occult blood test in the 2007 Swiss Health Interview Survey respondents aged 50 years and older.
Spaeth A; Zwahlen M
Endoscopy; 2013 Jul; 45(7):560-6. PubMed ID: 23780844
[TBL] [Abstract][Full Text] [Related]
36. Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort.
Weber MF; Banks E; Ward R; Sitas F
J Med Screen; 2008; 15(3):137-42. PubMed ID: 18927096
[TBL] [Abstract][Full Text] [Related]
37. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
[TBL] [Abstract][Full Text] [Related]
38. Do socioeconomic factors play a role in nonadherence to follow-up colonoscopy after a positive faecal immunochemical test in the Flemish colorectal cancer screening programme?
Hoeck S; van de Veerdonk W; De Brabander I
Eur J Cancer Prev; 2020 Mar; 29(2):119-126. PubMed ID: 31724969
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
40. Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
Osborne JM; Wilson C; Duncan A; Cole SR; Flight I; Turnbull D; Hughes DL; Young GP
BMC Public Health; 2017 Aug; 18(1):81. PubMed ID: 28764667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
